1. Home
  2. LYEL vs DKL Comparison

LYEL vs DKL Comparison

Compare LYEL & DKL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LYEL
  • DKL
  • Stock Information
  • Founded
  • LYEL 2018
  • DKL 2012
  • Country
  • LYEL United States
  • DKL United States
  • Employees
  • LYEL N/A
  • DKL N/A
  • Industry
  • LYEL Biotechnology: Pharmaceutical Preparations
  • DKL Natural Gas Distribution
  • Sector
  • LYEL Health Care
  • DKL Energy
  • Exchange
  • LYEL Nasdaq
  • DKL Nasdaq
  • Market Cap
  • LYEL 263.9M
  • DKL 2.1B
  • IPO Year
  • LYEL 2021
  • DKL N/A
  • Fundamental
  • Price
  • LYEL $0.65
  • DKL $42.07
  • Analyst Decision
  • LYEL Sell
  • DKL Buy
  • Analyst Count
  • LYEL 2
  • DKL 4
  • Target Price
  • LYEL $1.00
  • DKL $44.00
  • AVG Volume (30 Days)
  • LYEL 1.3M
  • DKL 207.7K
  • Earning Date
  • LYEL 02-26-2025
  • DKL 02-25-2025
  • Dividend Yield
  • LYEL N/A
  • DKL 10.44%
  • EPS Growth
  • LYEL N/A
  • DKL N/A
  • EPS
  • LYEL N/A
  • DKL 2.83
  • Revenue
  • LYEL $63,000.00
  • DKL $984,922,000.00
  • Revenue This Year
  • LYEL N/A
  • DKL N/A
  • Revenue Next Year
  • LYEL N/A
  • DKL $2.39
  • P/E Ratio
  • LYEL N/A
  • DKL $14.86
  • Revenue Growth
  • LYEL N/A
  • DKL N/A
  • 52 Week Low
  • LYEL $0.58
  • DKL $37.02
  • 52 Week High
  • LYEL $3.26
  • DKL $47.67
  • Technical
  • Relative Strength Index (RSI)
  • LYEL 34.74
  • DKL 71.78
  • Support Level
  • LYEL $0.60
  • DKL $40.40
  • Resistance Level
  • LYEL $0.71
  • DKL $41.33
  • Average True Range (ATR)
  • LYEL 0.06
  • DKL 0.85
  • MACD
  • LYEL 0.01
  • DKL 0.23
  • Stochastic Oscillator
  • LYEL 23.51
  • DKL 83.12

About LYEL Lyell Immunopharma Inc.

Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.

About DKL Delek Logistics Partners L.P. Common Units representing Limited Partner Interests

Delek Logistics Partners LP owns and operates logistics and marketing assets for crude oil and intermediate and refined products. The company's segment includes Pipelines and Transportation; Pipelines and Transportation and Investments in Pipeline Joint Ventures. It generates maximum revenue from the Pipelines and Transportation segment. The pipelines and Transportation segment consist of pipelines, tanks, offloading facilities, trucks, and ancillary assets, which provide crude oil gathering and crude oil, intermediate and refined products transportation and storage services in support of Delek Holdings' refining operations in Tyler, Texas, El Dorado, Arkansas and Spring, Texas.

Share on Social Networks: